Skip to main content
padlock icon - secure page this page is secure

Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics was previously published as Cancer Communications.

Publisher: Cognizant Communication Corporation

Volume 6, Numbers 10-11, 1994
Purchase this issue

Articles

INSTRUCTIONS TO CONTRIBUTORS
pp. Instructions-1-Instructions-2(2)

Favourites:
ADD

ABBREVIATIONS USED IN THIS JOURNAL
pp. Abbreviations-1-Abbreviations-2(2)

Favourites:
ADD

Commentary

Introduction
pp. 459-459(1)

Favourites:
ADD

Xanthine Dehydrogenase and Its Role in Cancer Chemotherapy
pp. 477-481(5)
Authors: Pritsos, Chris A.; Gustafson, Daniel L.

Favourites:
ADD

Novel N-oxides as Bioreductive Drugs
pp. 483-491(9)
Author: Naylor, M. A.

Favourites:
ADD

Bioactivation of Quinones by DT-diaphorase, Molecular, Biochemical, and Chemical Studies
pp. 493-500(8)
Authors: Ross, David; Beall, Howard; Traver, Robert D.; Siegel, David; Phillips, Roger M.; Gibson, Neil W.

Favourites:
ADD

Mitomycin C: A Prototype Bioreductive Agent
pp. 501-508(8)
Authors: Sartorelli, Alan C.; Hodnick, William F.; Belcourt, Michael F.; Tomasz, Maria; Haffty, Bruce; Fischer, James J.; Rockwell, Sara

Favourites:
ADD

Clinical Research

Favourites:
ADD

Clinical Studies with EO9, a New Indoloquinone Bioreductive Alkylating Cytotoxic Agent
pp. 519-523(5)
Authors: Verweij, Jaap; Aamdal, Steiner; Schellens, Jan; Koier, Ineke; Lund, Birthe; EORTC Early Clinical Trials Group

Favourites:
ADD

Laboratory Research

NAD(P)H:Quinone Oxidoreductase1 (DT-diaphorase): Expression, Regulation, and Role in Cancer
pp. 525-532(8)
Authors: Joseph, Pius; Xie, Tao; Xu, Yuehang; Jaiswal, Anil K.

Favourites:
ADD

Aliphatic Amine N-oxides of DNA Binding Agents as Bioreductive Drugs
pp. 533-538(6)
Authors: Patterson, Laurence H.; Craven, Michael R.; Fisher, Geoffrey R.; Teesdale-Spittle, Paul

Favourites:
ADD

The Thioredoxin/Thioredoxin Reductase Redox System and Control of Cell Growth
pp. 539-544(6)
Authors: Powis, Garth; Oblong, John E.; Gasdaska, Pamela Y.; Berggren, Margareta; Hill, Simon R.; Kirkpatrick, D. Lynn

Favourites:
ADD

Disulfide Cytotoxicity under Hypoxia
pp. 545-552(8)
Authors: Kirkpatrick, D. Lynn; Abu Sa’da, Issam; Chernoff, Wayne; Kuperus, Miles

Favourites:
ADD

Articles

Favourites:
ADD

The complete issue is available for purchase

$110.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more